Nuvectis Pharma Inc.
(NVCT)
undefined
undefined%
At close: undefined
4.70
-0.69%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | - | 149.00K | - | - |
Cost of Revenue | 22.90M | 19.23M | 12.89M | - |
Gross Profit | -22.90M | -19.09M | -12.89M | - |
Operating Income | -22.90M | -19.23M | -12.89M | -10.00K |
Interest Income | 637.00K | 149.00K | 4.00K | - |
Pretax Income | -22.26M | -19.09M | -12.89M | -10.00K |
Net Income | -22.26M | -18.79M | -12.89M | -10.00K |
Selling & General & Admin | 7.52M | 6.01M | 3.35M | 10.00K |
Research & Development | 15.38M | 13.23M | 9.54M | - |
Other Expenses | - | - | - | - |
Operating Expenses | 22.90M | 19.23M | 12.89M | 10.00K |
Interest Expense | - | 149.00K | - | - |
Selling & Marketing Expenses | 14.00K | - | - | 9.98K |
Cost & Expenses | 22.90M | 19.23M | 12.89M | 10.00K |
Income Tax | - | -298.00K | -4.00K | -24 |
Shares Outstanding (Basic) | 15.56M | 12.66M | 12.72M | 12.72M |
Shares Outstanding (Diluted) | 15.56M | 12.66M | 12.72M | 12.72M |
EPS (Basic) | -1.43 | -1.48 | -1.01 | -0.00 |
EPS (Diluted) | -1.43 | -1.48 | -1.01 | -0.00 |
EBITDA | -22.90M | -19.23M | -12.89M | - |
Depreciation & Amortization | -1.00M | -1.20M | -7.10M | 24.00K |